Described herein are pharmaceutical packaging programs which reduce oxidative degradation of morphine, hydromorphone, promethazine and also other oxygen-delicate drugs, such systems including a syringe by having an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with extremely minimal permeability to oxygen and comprises ethylene vinyl, and an https://rylanmdrzo.rimmablog.com/34761703/detailed-notes-on-trazodone-for-sleep